ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "outcomes"

  • Abstract Number: 2707 • 2018 ACR/ARHP Annual Meeting

    Scleroderma Renal Crisis: The Association of High-Dose Steroids and Poor Outcome

    Nilasha Ghosh1, Xuan Cai2 and Cybele Ghossein3, 1Internal Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, 2Center for Translational Metabolism and Health, Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, 3Nephrology, Northwestern University Feinberg School of Medicine, Chicago, IL

    Background/Purpose: Scleroderma renal crisis (SRC) is the most acute and life-threatening complication of scleroderma characterized by sudden increase in blood pressure and worsening kidney function.…
  • Abstract Number: 1747 • 2018 ACR/ARHP Annual Meeting

    Long-Term Outcomes of Patients with Nonsevere Eosinophilic Granulomatosis with Polyangiitis Given Azathioprine and Glucocorticoids for Remission Induction

    Xavier Puéchal1, Christian Pagnoux2, Gabriel Baron3, François Lifermann4, Loïk Geffray5, Thomas Quémeneur6, Jean-Luc Saraux7, Marie Wislez8, Vincent Cottin9, Marc Ruivard10, Nicolas Limal11, Achille Aouba12, Bernard Bonnotte13, Antoine Neel14, Christian Agard15, Pascal Cohen16, Benjamin Terrier17, Claire Le Jeunne17, Luc Mouthon1, Philippe Ravaud3 and Loïc Guillevin for the French Vasculitis Study Group17, 1Department of Internal Medicine, INSERM Unité 1016, Centre de Référence pour les Maladies Auto-immunes Rares, National Referral Center for Rare Systemic Autoimmune Diseases, Paris Cochin, France, Paris, France, 2Division of Rheumatology, Division of Rheumatology, Mount Sinai Hospital, Toronto, ON, Canada, 3Paris Hôtel Dieu, Paris, France, 4Dax, Dax, France, 5Lisieux, Lisieux, France, 6Department of Internal Medicine, CH of Valenciennes, France, Valenciennes, France, 7Eaubonne, Eaubonne, France, 8Paris Tenon, Paris, Gambia, 9Lyon Louis Pradel, Lyon, France, 10Clermont-Ferrand, Clermont Ferrand, France, 11Créteil Henri Mondor, Créteil, France, 12Caen, Caen, France, 13Dijon, Dijon, France, 14Medecine Interne, Nantes Hôtel Dieu, Nantes, France, 15Nantes Hôtel Dieu, Nantes, France, 16Department of Internal Medicine, INSERM Unité 1016, Centre de Référence pour les Maladies Auto-immunes Rares, Hôpital Cochin, Université Paris Descartes, Sorbonne Paris Cité, Paris, France, 17National Referral Center for Rare Systemic Autoimmune Diseases, Paris Cochin, France, Paris, France

    Background/Purpose: At month 24 (M24), CHUSPAN2-trial patients with nonsevere eosinophilic granulomatosis with polyangiitis (EGPA), who received 1 yr of azathioprine (AZA) and glucocorticoids (GC) as…
  • Abstract Number: 2721 • 2018 ACR/ARHP Annual Meeting

    Venous Thromboembolism in ANCA Associated Vasculitis. a Population-Based Cohort Study from Southern Sweden

    Matina Liapi1, David Jayne2, Mårten Segelmark3 and Aladdin Mohammad4, 1Medicine, Blekinge Hospital, Karlskrona, Sweden, 2Department of Medicine, University of Cambridge, Cambridge, United Kingdom, 3Clinical Sciences, Nephrology, Lund University, Lund, Sweden, 4Rheumatology, Department of Clinical Sciences, Lund, Lund University, Lund, Sweden

    Background/Purpose: To estimate the rate and predictors of venous thromboembolic events (VTEs) in a population-based cohort of patients with ANCA- associated vasculitis (AAV). Methods: 322…
  • Abstract Number: 1846 • 2018 ACR/ARHP Annual Meeting

    Menarchal Status at Diagnosis and Final Height in Females with Childhood-Onset Systemic Lupus Erythematosus

    Watchareewan Sontichai1, Daniela Dominguez1, Lawrence Ng1, Deborah M. Levy1, Jonathan Wasserman2, Earl Silverman1 and Linda Hiraki1, 1Division of Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, 2Division of Endocrinology, The Hospital for Sick Children, Toronto, ON, Canada

    Background/Purpose: The diagnosis of systemic lupus erythematosus (SLE) in childhood affects growth due to disease and therapy. To date, there are few studies of final…
  • Abstract Number: 2779 • 2018 ACR/ARHP Annual Meeting

    Long-Term Outcome and Prognostic Factors after Aortic Valve Surgery Due to Aortic Valve Regurgitation in Patients with Takayasu Arteritis

    So Hye Nam1, Dae-Hee Kim2, Doo-Ho Lim3, Ji Seon Oh1, Seokchan Hong1, Yong-Gil Kim1, Chang Keun Lee1 and Bin Yoo1, 1Division of Rheumatology, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea, Republic of (South), 2Division of Cardiology, Department of Internal medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea, Republic of (South), 3Division of Rheumatology, Department of Internal Medicine, University of Ulsan College of Medicine, Ulsan University Hospital, Ulsan, Korea, Republic of (South)

    Background/Purpose: Aortic valve (AV) surgery is often performed for aortic regurgitation (AR) in patients with Takayasu arteritis (TA). However, data on the long-term outcomes, including…
  • Abstract Number: 296 • 2018 ACR/ARHP Annual Meeting

    Does Care By a Multidisciplinary Team Improve Outcomes in Rheumatoid Arthritis? a Randomized Controlled Study

    Manjari Lahiri1,2, Peter P.M. Cheung1,2, Preeti Dhanasekaran2, Su Ren Wong3, Ai Yap3, Daphne Tan3, Amelia Santosa1,2 and Phillip HC Phan2, 1Division of Rheumatology, University Medicine Cluster, National University Hospital, Singapore, Singapore, Singapore, 2Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore, 3Department of Rehabilitation, National University Hospital, Singapore, Singapore, Singapore

    Background/Purpose: Quality standards recommend an annual review by a multidisciplinary team (MDT) for all patients with rheumatoid arthritis (RA); however, this is based on expert…
  • Abstract Number: 1850 • 2018 ACR/ARHP Annual Meeting

    A Population Based Study of High School Academic Outcomes in Individuals with Childhood-Onset Chronic Rheumatic Diseases in Manitoba, Canada

    Siok Hoon Lily Lim1,2, Ruth Ann Marrie3, Okechukwu Ekuma4, Marni Brownell4, Christine A. Peschken5, Carol A Hitchon6, Kerstin Gerhold7,8 and Lisa Lix9, 1Children's Hospital Research Institute of Manitoba, University of Manitoba, Winnipeg, MB, Canada, 2Pediatrics, University of MAnitoba, Winnipeg, MB, Canada, 3Internal Medicine, University of Manitoba, Winnipeg, MB, Canada, 4Manitoba Centre for Health Policy, University of Manitoba, Winnipeg, MB, Canada, 5RR 149G, University of Manitoba, Winnipeg, MB, Canada, 6University of Manitoba, Winnipeg, MB, Canada, 7Pediatrics, University of Manitoba, Winnipeg, MB, Canada, 8Faculty of Health Sciences, Children's Hospital Research Institute of Manitoba, Winnipeg, MB, Canada, 9Community Health Sciences, University of Manitoba, Winnipeg, MB, Canada

    Background/Purpose: Childhood-onset chronic rheumatic diseases (ChildCRD) are rheumatic diseases with onset <18 years old, including juvenile arthritis (JA) and systemic autoimmune rheumatic diseases (SARD). ChildCRD…
  • Abstract Number: 2876 • 2018 ACR/ARHP Annual Meeting

    Torque Teno Virus Quantification for Functional Monitoring of Immunomodulation with Biological Compounds in the Treatment of Rheumatoid Arthritis

    Paul Studenic1, Gregor Bond2, Andreas Kerschbaumer3, Manuel Bécède3, Karel Pavelka4, Dmitry Karateev5, Jutta Stieger6, Rudolf Puchner7, Ruediger Mueller8, Elisabeth Puchhammer-Stöckl9, Martina Durechova10, Michaela Loiskandl10, Thomas Perkmann11, Marta Olejarova4, Elena Luchikhina12, Carl-Walter Steiner13, Michael Bonelli10, Josef S. Smolen14 and Daniel Aletaha10, 1Division of Rheumatology, Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, 2Internal Medicine 3, Division of Nephrology, Medical University of Vienna, Vienna, Austria, 3Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, 4Department of Experimental Rheumatology, 1st Faculty of Medicine, Institute of Rheumatology, Charles University in Prague, Prague, Czech Republic, 5Department of Rheumatology, Department of Rheumatology, Moscow Regional Research and Clinical Institute (MONIKI), Moscow, Russian Federation, 62nd Deparment of Medicine, 2nd Deparment of Medicine, Hitzing Hospital, Vienna, Austria, 7Private Office, Wels, Austria, 8Division of Rheumatology, Immunology and Rehabilitation, Division of Rheumatology, Immunology and Rehabilitation, Kantonsspital St Gallen, St. Gallen, Switzerland, 9Institute for Virology, Institute for Virology, Medical University of Vienna, Vienna, Austria, 10Department of Internal Medicine 3, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, 11Department of Laboratory Medicine, Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria, 12Department of rheumatology, Moscow Regional Research and Clinical Institute (MONIKI), Moscow, Russian Federation, 13Internal Medicine 3, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, 14Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Vienna, Austria

    Background/Purpose: Rheumatoid arthritis (RA) patients who fail to respond to methotrexate (MTX) can be subjected to an addition of biologic disease-modifying antirheumatic drug (bDMARD). Currently…
  • Abstract Number: 459 • 2018 ACR/ARHP Annual Meeting

    Readmission Rate within 30 Days of Hospitalization Due to New Onset Lupus Nephritis and Associated Risk Factors: The Importance of Intravenous Pulse Methylprednisolone Therapy

    Angel Alberto Herrera Guerra1, Sampath Prahalad1, Kelly A. Rouster-Stevens1, Rouba Garro2, Leah Bryan3 and Yin Hong4, 1Pediatric Rheumatology, Emory University School of Medicine, Atlanta, GA, 2Pediatric Nephrology, Emory University School of Medicine, Atlanta, GA, 3Pediatrics, Emory University School of Medicine, Atlanta, GA, 4Pathology, Children's Health Care of Atlanta, Atlanta, GA

    Background/Purpose: There is a paucity of data regarding the early hospital readmission rates in newly diagnosed childhood lupus nephritis (cLN). We conducted a retrospective study…
  • Abstract Number: 1882 • 2018 ACR/ARHP Annual Meeting

    Characteristics and Treatment Outcomes of Takayasu Arteritis in a Nationwide, Retrospective Cohort Study in Japan

    Haruhito A. Uchida1, Yoshikazu Nakaoka2, Hajime Yoshifuji3, Takahiko Sugihara4, Yoshiko Watanabe5, Masayoshi Harigai6, Yoshihiro Arimura7 and Mitsuaki Isobe8, 1Department of Chronic Kidney Disease and Cardiovascular Disease, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan, 2Department of Vascular Physiology, National Cerebral and Cardiovascular Center Research Institute, Osaka, Japan, 3Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan, 4Department of Medicine and Rheumatology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan, 5First Department of Physiology, Kawasaki Medical School, Kurashiki, Japan, 6Tokyo Women's Medical University, Division of Epidemiology and Pharmacoepidemiology of Rheumatic Diseases, Institute of Rheumatology, Tokyo, Japan, 7Kyorin University School of Medicine, First Department of Internal Medicine, Tokyo, Japan, 8Sakakibara Heart Institute, Tokyo, Japan

    Background/Purpose: Takayasu arteritis (TAK) typically affects young women under 40 years old, whereas patients with onset age over 40 years are occasionally observed. It still…
  • Abstract Number: 477 • 2018 ACR/ARHP Annual Meeting

    Early Treatment with Intravenous Pulse Methylprednisolone or Methotrexate Is Associated with Decreased Medication Requirements at 12 and 24 Months in Patients with Juvenile Dermatomyositis: A Propensity Score Analysis

    Takayuki Kishi1,2, Jesse Wilkerson3, Marjo Smith3, Nastaran Bayat1, Michael Henrickson4, Bianca Lang5, Murray Passo6, Frederick W. Miller1, Michael Ward7 and Lisa G. Rider1, 1Environmental Autoimmunity Group, National Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, MD, 2Department of Pediatrics, Tokyo Women's Medical University, Tokyo, Japan, 3Social & Scientific Systems, Inc., Durham, NC, 4Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 5Department of Pediatrics, IWK Health Centre and Dalhousie University, Halifax, NS, Canada, 6Division of Rheumatology PTD, Medical University of South Carolina, Charleston, SC, 7National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD

    Background/Purpose: Daily oral prednisone has been the main therapy in juvenile dermatomyositis (JDM), and combination therapy with methotrexate (MTX) introduced soon after diagnosis has been…
  • Abstract Number: 2359 • 2018 ACR/ARHP Annual Meeting

    Systemic Lupus Erythematous Outcome Concerns: Identifying Pain As the Major Discrepancy between Rheumatologists and Patients

    Isabela Bertoglio1, Glaucia Abrahão1, Eloisa Bonfa2 and Michelle Lopes3, 1Rheumatology, Hospital das Clínicas da Faculdade de Medicina da USP, São Paulo, Brazil, 2Rheumatology Division, Hospital das Clinicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil, 3Rheumatology Division, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil

    Background/Purpose: Now-a-days there is a growing trend of switching to a more patient-centered healthcare system, with a widespread use of patient-reported outcomes (PROs). However, most…
  • Abstract Number: 604 • 2018 ACR/ARHP Annual Meeting

    Combining Observational and Randomized Controlled Trial Data Evidence to Jointly Estimate Remission and Response for Biologic and Non-Biologic Therapies in Rheumatoid Arthritis: A Bivariate Network Meta-Analysis

    Gyanendra Pokharel1, Rob Deardon1, Cheryl Barnabe2, Vivian P. Bykerk3, Susan J. Bartlett4, Louis Bessette5, Gilles Boire6, Carol Hitchon7, Edward C. Keystone8, Janet E. Pope9, Diane Tin10, Carter Thorne11 and Glen Hazlewood12, 1Department of Mathematics and Statistics, University of Calgary, Calgary, AB, Canada, 2Medicine, University of Calgary, Calgary, AB, Canada, 3Hospital for Special Surgery, New York, NY, 4Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 5Division of Rheumatology, Department of Medicine, CHU de Québec-Université Laval, Québec, QC, Canada, 6Rheumatology Division, Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre Hospitalier Universitaire de Sherbrooke and Universite de Sherbrooke, Sherbrooke, QC, Canada, 7University of Manitoba, Winnipeg, MB, Canada, 8Mount Sinai Hospital, Toronto, ON, Canada, 9Department of Medicine, University of Western Ontario, London, ON, Canada, 10The Arthritis Program, Southlake Regional Health Centre, Newmarket, ON, Canada, 11University of Toronto, Newmarket, ON, Canada, 12Departments of Medicine and Community Health Sciences, University of Calgary, Calgary, AB, Canada

    Background/Purpose: Remission is the goal of rheumatoid arthritis (RA) treatment, but ACR responses are more commonly measured in clinical trials. As such, data on remission…
  • Abstract Number: 2406 • 2018 ACR/ARHP Annual Meeting

    Clinical Presentation, Management and Long Term Outcome of Pars Planitis (PP), Panuveitis (PU) and Vogt–Koyanagi–Harada Disease (VKH) in Children and Adolescents

    Andreas Reiff, Children’s Hospital of Los Angeles, Los Angeles, CA

    Background/Purpose: Chronic uveitis is a common manifestation of pediatric rheumatologic conditions and may result in irreversible blindness and long term disability. While chronic anterior uveitis…
  • Abstract Number: 717 • 2018 ACR/ARHP Annual Meeting

    The Burden of Chronic Kidney Disease in Systemic Lupus Erythematosus (SLE): A Nationwide Epidemiologic Study

    Arthur Mageau1, Jean Francois Timsit1, Anne Perozziello1, Stephane Ruckly1, Claire Dupuis1, Lila Bouadma1, Thomas Papo1 and Karim Sacre2, 1Université Paris-Diderot, Paris, France, 2Bichat Hospital, Paris Diderot University, Paris, France

    Background/Purpose: Lupus nephritis occurs in about 50% of SLE patients. We aimed to analyze the impact of chronic kidney disease (CKD) on major clinical outcomes…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 10
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology